Chimerix (CMRX) Reaches New Lifetime High Today

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Chimerix ( CMRX) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Chimerix as such a stock due to the following factors:

  • CMRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $31.2 million.
  • CMRX has traded 2,379 shares today.
  • CMRX is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CMRX with the Ticky from Trade-Ideas. See the FREE profile for CMRX NOW at Trade-Ideas

More details on CMRX:

Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals to address unmet medical needs in the United States. Currently there are 9 analysts that rate Chimerix a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Chimerix has been 399,500 shares per day over the past 30 days. Chimerix has a market cap of $1.8 billion and is part of the health care sector and drugs industry. The stock has a beta of -0.15 and a short float of 8.6% with 3.96 days to cover. Shares are up 5.4% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Chimerix (CMRX) Is Strong On High Volume Today

7 Stocks Under $10 Making Big Moves

Chimerix (CMRX) Weak On High Volume

Chimerix (CMRX) Flagged As Strong On High Volume

8 Stocks Under $10 to Trade for Big Gains